Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation

By Simbionix Ltd., PRNE
Tuesday, June 29, 2010

CLEVELAND, Ohio, June 30, 2010 - Simbionix Ltd., a subsidiary of Simbionix USA Corporation, the world's
leading provider of medical education and simulation training products for
medical professionals and the healthcare industry, and USF Health, an
organization dedicated to creating a model of health care based on
understanding the full spectrum of health, are proud to announce that
together they received a BIRD (Binational Industrial Research and
Development) Grant to support the development of a Laparoscopic Hysterectomy
simulation module.

The BIRD Foundation was established by the U.S. and Israeli governments
in 1977 to generate mutually beneficial cooperation between the private
sectors of the U.S. and Israeli high tech industries, including start-ups and
established organizations. BIRD provides both matchmaking services between
U.S. and Israeli companies, as well as funding covering up to 50 percent of
project development and initial product commercialization costs.

Developing this new Laparoscopic Hysterectomy module supports Simbionix'
goal for including complex advanced procedures in their comprehensive LAP
Mentor(TM) Simulator. It also reaffirms Simbionix' commitment towards
improving the quality of care in the field of Women's Health. Approximately
600,000 hysterectomies are performed annually in the US, making it the second
most frequently performed major surgical procedure. The Laparoscopic
Hysterectomy procedure requires greater surgical skills than the vaginal and
abdominal methods, and as such necessitates performing approximately 15
procedures before surgeons become proficient. Since this procedure is
difficult to teach using conventional methods, practicing Ob-Gyns may have
never received laparoscopic training during their residency. The new module
will use medical simulation teaching methods to provide the necessary complex
skills acquisition and training for surgeons.

Dr. Stephen K. Klasko, CEO of USF Health and Dean of the USF College of
Medicine stated: "As simulation technology expands its use as a driver for
quality and safety in medicine, it will take great organizations working
together. At USF Health, we have been a leader in applying technology to
improve the health of our community. Over the past year, USF Health has had
the opportunity to work with Simbionix, the world's leading provider of
medical education and simulation products to deliver training for medical
students, residents, practicing physicians and other healthcare professionals
to enhance technical competence and improve patient outcomes. The award of
the BIRD grant provides a fantastic opportunity for us to work with Simbionix
to develop the first laparoscopic hysterectomy simulation module for training
GYN surgeons in minimally invasive surgery techniques. This project has the
potential to have a huge impact on the quality of practice of gynecologists
worldwide. Through us working together, our doctors, our patients and the
health of our communities will stand to be the winners."

"Simbionix makes it a priority to cooperate with the medical community on
a regular basis for the advancement of medical education and training" says
Simbionix President Ran Bronstein. "We are honored to have received this
grant and to be working on this exciting project in conjunction with USF.
Simbionix' unique, advanced simulation technology, combined with the clinical
and educational expertise of USF Health's collaborating physicians, and USF
Health's experience in integrating medical simulation into certifiable
curricula, will ensure that the advanced GYN - Hysterectomy simulation module
will truly be an innovative and critical contribution to improving women's

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training
products for medical professionals and the healthcare industry. Founded in
1997, the company is committed to delivering high quality products, advancing
clinical performance and optimizing procedural outcomes.

For more information on Simbionix, visit

About USF Health

USF Health ( is dedicated to creating a model
of health care based on understanding the full spectrum of health. It
includes the University of South Florida's colleges of medicine, nursing, and
public health; the schools of biomedical sciences as well as physical therapy
& rehabilitation sciences; and the USF Physicians Group. With more than
$380.4 million in research grants and contracts last year, the University of
South Florida
is one of the nation's top 63 public research universities and
one of only 25 public research universities nationwide with very high
research activity that is designated as community-engaged by the Carnegie
Foundation for the Advancement of Teaching.

    Rebecca Zitter
    Manager of Marketing Communications and Distributor Relations

Contact: Rebecca Zitter, +12162292040, Manager of Marketing Communications and Distributor Relations, Rebecca at

will not be displayed